Abstract
Drug-eluting stents with biodegradable polymers have been developed to reduce the risk of very late adverse events such as stent thrombosis. Recent studies have indicated similar results with regard to safety outcomes for the biodegradable polymer-coated biolimus-eluting stent (Nobori™; BES)
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
